Ahmed T - Search Results

1

Preliminary Experience with Short Course High-Dose Mitoxantrone in Combination with High-Dose Cytarabine in Patients with Acute Leukemia and Blastic Phase of Chronic Myelogenous Leukemia.

Feldman EJ, Biguzzi S, Ahmed T, Mittelman A, Puccio CA, Baskind P, Arlin ZA. Feldman EJ, et al. Among authors: ahmed t. Leuk Lymphoma. 1990;3(3):209-11. doi: 10.3109/10428199009050997. Leuk Lymphoma. 1990. PMID: 27457439

2

Homoharringtonine is safe and effective for patients with acute myelogenous leukemia.

Feldman E, Arlin Z, Ahmed T, Mittelman A, Puccio C, Chun H, Cook P, Baskind P. Feldman E, et al. Among authors: ahmed t. Leukemia. 1992 Nov;6(11):1185-8. Leukemia. 1992. PMID: 1434802 Clinical Trial.

3

Homoharringtonine in combination with cytarabine for patients with acute myelogenous leukemia.

Feldman E, Arlin Z, Ahmed T, Mittelman A, Puccio C, Chun H, Cook P, Baskind P. Feldman E, et al. Among authors: ahmed t. Leukemia. 1992 Nov;6(11):1189-91. Leukemia. 1992. PMID: 1434803 Clinical Trial.

4

Short course high dose mitoxantrone with high dose cytarabine is effective therapy for adult lymphoblastic leukemia.

Arlin ZA, Feldman EJ, Finger LR, Ahmed T, Mittelman A, Cook P, Puccio C, Baskind P, Arnold P, Razis ED, et al. Arlin ZA, et al. Among authors: ahmed t. Leukemia. 1991 Aug;5(8):712-4. Leukemia. 1991. PMID: 1886423

5

High-dose, potentially myeloablative chemotherapy and autologous bone marrow transplantation for patients with advanced Hodgkin's disease.

Ahmed T, Ciavarella D, Feldman E, Ascensao J, Hussain F, Engelking C, Gingrich S, Mittelman A, Coleman M, Arlin ZA. Ahmed T, et al. Leukemia. 1989 Jan;3(1):19-22. Leukemia. 1989. PMID: 2642573 Review.

6

Amsacrine with high-dose cytarabine is highly effective therapy for refractory and relapsed acute lymphoblastic leukemia in adults.

Arlin ZA, Feldman E, Kempin S, Ahmed T, Mittelman A, Savona S, Ascensao J, Baskind P, Sullivan P, Fuhr HG, Mertelsmann R. Arlin ZA, et al. Among authors: ahmed t. Blood. 1988 Aug;72(2):433-5. Blood. 1988. PMID: 3165293 Free article.

7

Bone marrow transplantation for chronic myelogenous leukemia: some thoughts about future prospects.

Ahmed T, Arlin ZA. Ahmed T, et al. Leukemia. 1988 Mar;2(3):181. Leukemia. 1988. PMID: 3279274 No abstract available.

8

Pilot study of all-trans retinoic acid as post-remission therapy in patients with acute promyelocytic leukemia.

Seiter K, Miller WH Jr, Feldman EJ, Ahmed T, Arlin Z. Seiter K, et al. Among authors: ahmed t. Leukemia. 1995 Jan;9(1):15-8. Leukemia. 1995. PMID: 7845010 Clinical Trial.

9

Phase I-II trial of high dose Ara-C, carboplatinum, etoposide and steroids in patients with refractory or relapsed lymphomas.

Ahmed T, Cook P, Feldman E, Coombe N, Puccio C, Mittelman A, Chun H, Coleman M, Helson L. Ahmed T, et al. Leukemia. 1994 Apr;8(4):531-4. Leukemia. 1994. PMID: 8152247 Clinical Trial.

10

Phase I clinical and pharmacokinetic evaluation of high-dose mitoxantrone in combination with cytarabine in patients with acute leukemia.

Feldman EJ, Alberts DS, Arlin Z, Ahmed T, Mittelman A, Baskind P, Peng YM, Baier M, Plezia P. Feldman EJ, et al. Among authors: ahmed t. J Clin Oncol. 1993 Oct;11(10):2002-9. doi: 10.1200/JCO.1993.11.10.2002. J Clin Oncol. 1993. PMID: 8410125 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,858 results

Search Page

Filters